News tagged with current market

FDA: Zofran 32-mg dose pulled from market

(HealthDay)—The 32-mg, single intravenous dose of Zofran (ondansetron), an anti-nausea drug, is being removed from the market due to its potential to cause serious, even fatal, cardiac damage, according to a Drug Safety ...

Dec 06, 2012
popularity0 comments 0

Sorry, no news articles match your request. Your search criteria may be too narrow.

Subscribe to rss feed